These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16421722)

  • 41. Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes.
    Gloger A; Ritz D; Fugmann T; Neri D
    Cancer Immunol Immunother; 2016 Nov; 65(11):1377-1393. PubMed ID: 27600516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-G in melanoma: can the current controversies be solved?
    Chang CC; Ferrone S
    Semin Cancer Biol; 2003 Oct; 13(5):361-9. PubMed ID: 14708716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumour-associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles.
    Kumar P; Boyne C; Brown S; Qureshi A; Thorpe P; Synowsky SA; Shirran S; Powis SJ
    Immunology; 2022 Jun; 166(2):249-264. PubMed ID: 35318648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
    Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
    Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
    Creary LE; Guerra SG; Chong W; Brown CJ; Turner TR; Robinson J; Bultitude WP; Mayor NP; Marsh SGE; Saito K; Lam K; Duke JL; Mosbruger TL; Ferriola D; Monos D; Willis A; Askar M; Fischer G; Saw CL; Ragoussis J; Petrek M; Serra-Pagés C; Juan M; Stavropoulos-Giokas C; Dinou A; Ameen R; Al Shemmari S; Spierings E; Gendzekhadze K; Morris GP; Zhang Q; Kashi Z; Hsu S; Gangavarapu S; Mallempati KC; Yamamoto F; Osoegawa K; Vayntrub T; Chang CJ; Hansen JA; Fernández-Viňa MA
    Hum Immunol; 2019 Jul; 80(7):449-460. PubMed ID: 30844424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA associations in the antitumor response against malignant melanoma.
    Marincola FM; Shamamian P; Rivoltini L; Salgaller M; Cormier J; Restifo NP; Simonis TB; Venzon D; White DE; Parkinson DR
    J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):242-52. PubMed ID: 8680652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines.
    Kirkin AF; Petersen TR; Olsen AC; Li L; thor Straten P; Zeuthen J
    Cancer Immunol Immunother; 1995 Aug; 41(2):71-81. PubMed ID: 7656272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. c-myc down-regulates class I HLA expression in human melanomas.
    Versteeg R; Noordermeer IA; Krüse-Wolters M; Ruiter DJ; Schrier PI
    EMBO J; 1988 Apr; 7(4):1023-9. PubMed ID: 3402430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients.
    Anichini A; Mortarini R; Nonaka D; Molla A; Vegetti C; Montaldi E; Wang X; Ferrone S
    Cancer Res; 2006 Jun; 66(12):6405-11. PubMed ID: 16778219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
    Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
    Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2.
    Mimura K; Ando T; Poschke I; Mougiakakos D; Johansson CC; Ichikawa J; Okita R; Nishimura MI; Handke D; Krug N; Choudhury A; Seliger B; Kiessling R
    Int J Cancer; 2011 Jan; 128(2):390-401. PubMed ID: 20715101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
    Chang CC; Campoli M; Restifo NP; Wang X; Ferrone S
    J Immunol; 2005 Feb; 174(3):1462-71. PubMed ID: 15661905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TypeLoader2: Automated submission of novel HLA and killer-cell immunoglobulin-like receptor alleles in full length.
    Schöne B; Fuhrmann M; Surendranath V; Schmidt AH; Lange V; Schöfl G
    HLA; 2019 Apr; 93(4):195-202. PubMed ID: 30821128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
    Darrow TL; Slingluff CL; Seigler HF
    J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
    Scholtalbers J; Boegel S; Bukur T; Byl M; Goerges S; Sorn P; Loewer M; Sahin U; Castle JC
    Genome Med; 2015 Nov; 7():118. PubMed ID: 26589293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating the utility of human melanoma cell lines as tumour models.
    Vincent KM; Postovit LM
    Oncotarget; 2017 Feb; 8(6):10498-10509. PubMed ID: 28060736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioinformatic databases and resources in the public domain to aid HLA research.
    Helmberg W
    Tissue Antigens; 2012 Oct; 80(4):295-304. PubMed ID: 22994154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.
    Holdsworth R; Hurley CK; Marsh SG; Lau M; Noreen HJ; Kempenich JH; Setterholm M; Maiers M
    Tissue Antigens; 2009 Feb; 73(2):95-170. PubMed ID: 19140825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.